- Open Access
- Open Peer Review
The experience of adolescents participating in a randomised clinical trial in the field of mental health: a qualitative study
© Midgley et al. 2016
- Received: 20 October 2015
- Accepted: 6 July 2016
- Published: 28 July 2016
This descriptive study aimed to investigate adolescents’ motivations for participating in a randomised controlled trial (RCT), to explore the understanding that the young people had regarding a number of aspects of the trial design, to examine whether or not they found participation in the trial to be acceptable and what affected this, and to identify whether and how the young people felt that their participation in the RCT impacted on their experience of therapy and on therapeutic change.
Seventy-six adolescents who were taking part in a large-scale RCT to evaluate the clinical and cost effectiveness of psychological therapies for depression were interviewed at two time-points after completing therapy. The semi-structured interviews, which included a focus on the young people’s experience of the research study, were analysed using framework analysis.
The vast majority of adolescents found it acceptable to participate in the clinical trial, and many agreed to participate for reasons of ‘conditional altruism’. However consent was often given without great understanding of the key elements of the trial, including the difference between treatment arms and the randomisation process. Although the adolescents were largely positive about their experiences from taking part, the study raises questions about whether clinical outcomes may be influenced by participation in the research elements of the trial.
Although adolescents are under-represented in clinical trials, those who do participate are generally positive about the experience; however, careful thought needs to be given to key elements of the trial design and the potential impact of the research participation on clinical outcomes.
ISRCTN registry, ISRCTN83033550. Registered on 15 October 2009.
- Randomised controlled trials
- Trial participation
- Patient understanding
- Patient perspective
- Qualitative research
- Framework analysis
In the most recent edition of their comprehensive review of ‘What works for whom?’ in the field of child and adolescent mental health, Fonagy et al.  expressed the view that randomised controlled trials (RCTs) are ‘generally considered scientifically superior to cohort or observational studies in answering the question of whether a treatment is effective’ (p. 4). Although these authors acknowledge the limitations of RCTs, this opinion is shared by most developers of guidelines on evidence-based practice such as those developed by the American Psychiatric Association in the USA or the National Institute for Health and Clinical Evidence in the UK.
Yet despite the importance of participation by adolescents, relatively little is known regarding how and why young people decide to participate in clinical trials, especially in the field of mental health, or how they then experience involvement in such studies . A recent study by Brown et al.  noted that adolescents are under-represented in clinical trials generally and that ‘little is known about adolescents’ knowledge and attitudes surrounding clinical trials’ (p. 213). Brown et al.’s own questionnaire survey of 82 high school students in Michigan found that only 33 % of those surveyed had ever heard of a clinical trial, and understanding about trials was poor. However, attitudes toward taking part were somewhat more positive.
The literature examining the experience of adults who have participated in clinical trials is somewhat more extensive. In a systematic review article by O’Cathain et al. , 54 studies were identified which had examined the design, process and conduct of clinical trials using qualitative methodologies. Among these were studies that examined how and why participants decided to take part in clinical trials, their understanding of trial design and whether trial design was considered acceptable to those who took part.
Most research examining the views of adults taking part in clinical trials has focused on studies evaluating medical treatments. However, Notley et al. , in a well-designed study examining the views of 13 young adults on their involvement in a trial of social recovery cognitive-behavioural therapy, found that practicalities relating to participation, such as the time and location of research meetings and flexibility in relation to these from the research staff, were important factors in the patient’s experience of taking part. Participants also expressed positive surprise at their levels of disclosure in research assessment meetings, and stated that this might have happened as a result of the researcher being supportive, non-judgmental and empathetic. Taken together, these findings may suggest that the patients’ experience of participation in a research trial is acceptable if they experience research staff in such positive ways and if they feel that they are getting something positive from the experience of taking part in the trial.
When it comes to adolescents, a certain amount of literature exists in the field of physical health—especially oncology—regarding the recruitment and decision-making process as to whether to participate in research or not, from the perspective of both adolescents and their parents (e.g. [5–8]). Very few studies, however, have focused on the experience of adolescents after they have chosen to participate in a trial, and research related to young people’s involvement in clinical trials evaluating the effectiveness of psychological therapies is completely lacking.
In conclusion, whilst a reasonable amount of knowledge is available about the experience of adults who have taken part in clinical trials in the field of medicine, and a few studies that have looked at the experience of those taking part in trials evaluating psychological therapies, no research is available that explored the experience of adolescents participating in clinical trials of psychological therapies, and relatively little research is available on young people's participation in clinical trials generally. Where such research has taken place, it has mostly focused on the decision to participate, with less attention paid to the experience of actually taking part in a trial. But exploring such experiences is important for two key reasons. First, it is essential to know whether the core elements of clinical trials (recruitment, randomisation, and on-going data collection) are understood and found acceptable or not to adolescents. Such information is crucial to inform the design of future clinical trials in a way that is ethical for those being asked to participate. Second, given the debates about the transferability of trial findings to the routine clinical practice , it is important to understand, from the perspective of the young people themselves, whether participating in the trial impacted on the treatment they received. Was the therapeutic impact of the intervention different because it was taking place in the context of a clinical trial?
The aims of this study, therefore, were (1) to explore adolescents’ understanding and motivations for participating in an RCT investigating the therapeutic efficacy of three treatments for adolescent depression, (2) to explore whether or not the young people found participation in the trial to be acceptable and what affected this, and (3) to explore whether and how the young people felt that their participation in the RCT impacted on their experience of therapy and upon therapeutic change.
Setting for the study
All the adolescents interviewed for this study were taking part in a large, multi-centre, randomised controlled trial, the Improving Mood through Psychoanalytic and Cognitive-Behavioural Therapy (IMPACT) Study (for full details of the study, see ). IMPACT is a pragmatic superiority trial comparing the relative clinical effectiveness of three psychological treatments for adolescent depression, with established evidence of efficacy for evoking clinical remission in the short term (i.e. 3–6 months). The three treatment approaches tested in this study were a manualised form of specialist clinical care termed brief psychosocial intervention (BPI), short-term psychoanalytic psychotherapy (STPP) and cognitive behavioural therapy (CBT).
Participants and recruitment
Potential participants in the IMPACT trial were identified by clinical staff from routine referrals to the participating Child and Adolescent Mental Health Service (CAMHS) clinics. The assessing clinicians informed the young person and the parents/carers about the trial and invited them to consider taking part. They were told that the study team would be in touch if they expressed an interest to participate, and that recruitment would depend on research assessments of whether the patient met the inclusion and the exclusion criteria.
The participants and their parents or legal guardians were then sent information sheets about the trial and were asked if they were willing to be contacted by a researcher, who then met participants and invited them to sign a consent form. In agreeing to participate in this pragmatic clinical trial, the young people were agreeing to be randomised to one of the three treatment arms. As the trial was examining levels of relapse in the medium term, participants were also agreeing to attend six research assessment meetings across an 86-week period, in each of which they and their parents or carers were asked to complete a substantial number of structured assessments. These assessments were a mixture of structured interviews and self-report questionnaires on various aspects of their psychological well-being, and usually took approximately 1.5 hours to complete (for full details, see ). The information sheet explained that young people would be offered a £10 voucher for attending each assessment meeting (see ). Following randomisation, all patients in the trial were treated by appropriately trained and supervised CAMHS staff working in the participating clinics.
A total of 465 young people were recruited to the IMPACT study, with a mean age of 15.6 years (SD 1.4). A total of 348 (75 %) were females, and 117 male (25 %). Of these participants, 85 % (382/450) described their ethnicity as White British. At the point at which the young people had been recruited to the study, all met the diagnostic criteria for moderate to severe depression, based on the Kiddie-SADS . The IMPACT study took place across different parts of the UK; the recruitment numbers were 127 for North London, 185 for East Anglia and 153 for the North-West (Manchester and the Wirral). Findings regarding the comparative clinical and cost effectiveness of the interventions are expected in 2016.
Alongside the IMPACT study, a sub-study known as IMPACT-ME  aimed to explore the experience of the participants taking part in the London arm of the IMPACT trial (for other findings from this study, see [13–15]). Recruitment for this sub-study began slightly later than the main clinical trial, in September 2011, with all young people recruited in London being asked for additional consent to take part in two semi-structured interviews taking place 36 weeks and 86 weeks after they had joined the IMPACT trial. The participants for the sub-study reported in this paper, therefore, were 76 adolescents who were recruited to the London arm of the IMPACT study between September 2011 and December 2012 and who completed at least one of the two post-therapy semi-structured interviews. Closely matching the total sample in the IMPACT trial, the average age of these 76 young people was 15.35 years, and 76 % were female. Based on a review of all key characteristics, this sub-sample was broadly representative of the participants in the London arm of the trial itself.
For the study reported here, a qualitative approach was taken, as the aim was to allow the young people to describe in depth their experience of participating in the trial, as well as their views of the psychological therapy and their understanding of any changes in their depression that took place during and after therapy. We chose qualitative research, because it aims to describe and understand social or human phenomena. The research process is reflexive and interactive and allows the participants to express their experiences in their own words. Verbal or visual data is interpreted based on distinct methodological traditions to get a complex holistic picture . In the current study, young people were interviewed using a semi-structured protocol, the Experience of Therapy Interview (ETI) (Midgley N, Ansaldo F, Parkinson S, Holmes J, Stapley E, Target M: Expectations of therapy interview (young person and parent versions), unpublished). The interview schedule covered three key areas: the difficulties that brought the young person into therapy, the participant’s experience of therapy, and how it had been to participate in the IMPACT study.
Interviews were conducted on two occasions: at the end of therapy (36 weeks) and again at 1-year follow-up (86 weeks). These interviews were carried out at a different time from the research assessment meetings for the IMPACT trial itself and by a different team of researchers (this was done primarily so that the research assistants working on the IMPACT trial would not be un-blinded to the treatment allocation, given that the qualitative interviews included an in-depth exploration of the young person’s experience of therapy; it also aimed to make it easier for the young people to speak openly about their experience of involvement in the trial, including both positive and negative aspects). In line with guidance on qualitative interviewing, researchers were encouraged to follow the young person’s lead, but follow up with further questions in order to gain as deep an understanding as possible of their experience. All interviews for this sub-study were carried out by post-graduate psychologists, who were given a half-day training session in semi-structured interviewing using the ETI, and were offered feedback on interviewing technique following their initial interviews with young people.
Interviews were audio-recorded with interviewee consent. The interviews at 36 weeks took place between October 2011 and January 2014, and the interviews at 86 weeks between August 2012 and January 2015; 70.5 % of the young people had interviews at both time points. All interviews took place in the young person's home or at their local CAMHS, depending on the young person’s preference.
All interviews were transcribed and then analysed using framework analysis (FA) , a method of qualitative data analysis that was originally developed in the context of social policy research in the UK but has recently become increasingly popular in the fields of nursing and psychology. Sitting within the family of broadly ‘thematic’ approaches, FA provides a flexible but structured approach to data management and data analysis, which is especially suitable for studies which have quite focused research questions, a relatively large amount of qualitative data that needs to be managed, and a priori issues to investigate . It also lends itself to studies where qualitative data analysis is carried out by a team working together, rather than an individual researcher. The approach has also been integrated with the NVivo10 qualitative software package , which was used in this study.
We followed the five stages of framework analysis, as outlined by Ritchie and Spencer . Two of the authors (DI and KW) developed a coding framework focusing on the main research questions, under the supervision of NM and MT. They coded the first 20 interviews together with the aim to develop a comprehensive, consistent and clear coding framework. The first author then coded a number of additional interviews using this framework, to ensure that it was sufficient, comprehensive and reliable. Further revisions were made to the coding framework based on this process, and then, DI and KW continued to code the remaining interviews using the coding framework. In addition to the inductive coding based on the framework, each case was coded at a global level in terms of main motivation for participation, general acceptability of participation, and the overall understanding/lack of understanding of participating in the RCT. Based on these ‘global’ ratings, frequencies will be reported in the results section. (A more detailed account of the use of framework analysis in this study can be found in ).
Findings are presented in three sections, following the three research aims of the study. Each section is reported in a narrative form, but numbers are given to indicate how common each theme was. However, not all participants made reference to experiences that related to every category within the framework, and in some cases, data from one interview could be coded to several categories (for example, when a young person spoke about several reasons for choosing to participate in the study); therefore, the total number of young people reported for each category does not always add up to 76. In our findings, the terms ‘young people’ and ‘adolescents’ are used interchangeably.
Young people’s understanding and motivations for participating in the RCT
I probably didn’t understand it as well as I should have. I don’t even know the one I’m doing now, it’s really bad. Because I was reading them and they all kind of sounded the same to me, apart from one with antidepressants or something. I didn’t really know the differences, I was just thinking I’m getting therapy, that’s that. (female, 16)
As far as I know it’s to do with working out what type of therapy works best for teenagers or people, I think it’s from 11 to 16 or something. Cos there was Cognitive Be- there was cognitive therapy, psychotherapy…um, one that was a bit more like counselling…and I think there was one other one. And then like we all got picked one at random and then…they checked – so they monitored us to see if we were getting better and then, from that they’d do something sciency and then work out which one’s best. (female, 14)
Well, I don’t know how much I’m helping but just knowing, just knowing that even if I contribute by one percent in helping another individual then I think that’s just, it’s better than zero percent. (female, 16)
It just sounded like it sounded like bigger, like more successful, and…that it might actually be able to help me. (female, 16)
He offered me IMPACT or he was like ‘well you can have normal therapy but you would have - but then you would be put onto a waiting list’…So I was like, yeah I’ll do IMPACT. (female, 17)
I like the idea they pay you for it. I’m not gonna lie (laughs). It’s really – it’s a very good incentive. (female, 17)
It’s weird to think that so many other people over the country are, like you know — people are coming to their house as well, and they’re getting interviewed and like spoken to. (female, 16)
The acceptability to young people of taking part in the trial
I think it’s been like quite a good experience… it feels interesting I suppose to- to know that like you’re kind of part of the study (female, 16)
Yeah, it was a really good way. And although I thought like, ‘Oh, you know like, why do they have to come. Like I’m better now’. But when they got here, and I actually started like talking to them and like doing the things I thought of…it felt good. It’s like you really can see the progress you’ve made. (female, 16)
Make [the research assessment meetings] not as long. They’re quite long and there’s lots of questionnaires and sometimes it’s difficult to answer everything right cos you’re just kind of ticking off stuff… Because sometimes you just – it gets to the point where you’re just like ‘ok, getting a bit tired of this now’ and then you don’t feel like what you’re saying is particularly useful because it’s not not true but not –you’re just saying things as quickly as possible cos you wanna stop. (male, 16)
There’s like loads of questions but like it really makes you think about stuff and it really like examines everything and even though I don’t like examining… it’s kind of like, I dunno, it felt like more helpful - like I thought about things that could be related, that wasn’t like my phobias and stuff and I was just like… it definitely - it definitely helped me understand myself a bit more. (female, 16)
I think it’s a good method… It’s not biased or anything so, yeah, so that’s better, randomly allocating them. (female, 15)
I just thought well they would know what, which treatment would be best for me so I didn’t really think about it that much. (female, 16)
I think maybe the random allocated way about it isn’t really the right way to go cos there’s obviously some people with worse issues than others, so if there’s different things that you can choose from, why would you randomly put them in, would you not want to kinda look at their background or ‘this would be better for that person, this would be better for that person’? (female, 15)
Oh no it was, it was before they actually told me about it ‘cause I thought they were, like I knew they were the all the same thing , but I didn’t realise they were helping for the same thing. ‘Cause when she said it was three different treatments , I thought they were completely different, but when she explained it, I realised they were all actually related, and to do with the same thing. (female, 16)
I probably didn’t understand it as well as I should have. I don’t even know the one I’m doing now, it’s really bad. Because I was reading them and they all kind of sounded the same to me, apart from one with antidepressants or something. I didn’t really know the differences, I was just thinking I’m getting therapy, that’s that. (female, 16)
Despite not fully understanding how the treatment options differed, 22 young people seemed to find the randomisation process fairly acceptable, particularly once they had been reassured that all three treatment arms were expected to be effective. In addition, they expressed that they were happy to be getting help, regardless of the treatment arm to which they were allocated, or that their lack of experience and knowledge about therapy meant that it would be better to ‘leave it to the experts’. The idea that randomisation was a ‘fair’ and ‘not biased’ way to decide which therapy each young person received was also expressed. In contrast to those unhappy about the outcome, 22 others seemed to be happy about the treatment allocated to them. These young people seemed to feel that they had been given ‘the correct’ treatment or the one they were hoping to get, or that any of the treatments would have been helpful.
They’d come to me so I was at my house, so I felt more comfortable. Rather than going to someone that I don’t really know, and going to a place that I’ve never been to before, you just felt more comfortable…and if I wanted to change to different question we could, and then we could come back to it. (female, 15)
However, 14 participants reported less positive experiences of the meetings with the research assistants. It was described as ‘weird’, ‘strange’, and ‘scary’ to have the research assistants come to the young person’s house and for the participant to tell this new person about their difficulties. For one young person it also felt ‘heavy’ to be asked questions about their difficulties, and another described disliking the approach that a research assistant took in persisting with a line of questioning, when the participant had given an answer.
To see so many different faces and to explain your story over and over and over again it is hard, it is difficult… I don’t know how many people I’ve had - I’ve had well over 20 people come to this house and see me and I’ve had to explain my story every single time. (female, 14)
It wasn’t too bad… I mean I didn’t really pay attention to the recorder that much… I mean I would occasionally look at it but I wouldn’t really… be wary of what I’m saying knowing that I’m being recorded. (male, 17)
How participating in the trial impacted on the experience of therapy and therapeutic change
I: How did you feel about those [research assessment] meetings…
P: They were alright… I thought they were just part of the therapy…
I: Right okay…
P: Well not part of the - cos they did ask me about my depression and stuff
P: Wait, are you the same people? (male, 17)
Cos obviously it’s not exactly the same as being in a room with your therapist, I mean it’s not exactly the same. I mean with these researchers you can say how your moods and stuff are, but with your therapist you can say like what has actually gone on altogether. (male, 15)
It almost feels like they’re the same thing but…they’re not […] Well the research is much more direct. I’m asked questions as opposed to I say what I want to say and sometimes it’s a bit more intense than just sitting there talking to someone. But it’s – it feels just fairly similar. (male, 16)
I think I enjoyed [the meetings with the research assistant] more than the weekly therapist’s. Because she’s really nice and she’s more near my age and I think that’s why I feel more comfortable with her, because we kind of talk about the same kind of stuff and almost have the same kind of interests and I think it’s easier when you’re talking to someone who’s close to your age, than someone who’s a lot older because they’ll understand more. So I felt a bit more comfortable with [the researcher]. (female, 16)
With therapy I think it was more on a formal level but then it was satisfying cos I could talk to her about anything that I really wanted to, but like I trusted her more the person more than like with the research. (female, 15)
I’ve really, really liked it, I mean just… having somebody have a little check up with you and knowing that… for instance although therapy didn’t work for me, I’m pretty sure that if I started feeling really bad again like IMPACT - I felt as if I could trust them that they would try and like sort something out for me. It’s just they’ve kinda always been in the background. (female, 17)
Like I think once you guys sent me this sheet thing and it had all these like facts on it, and it was like how many people are in the study. And I couldn’t believe it. Cos obviously like me, like I know – well, I don’t know for sure – but I’m sure most of the people that I know, that I’m around, aren’t going through, or haven’t been through anything. So I just think I’m a bit of the odd one out. But then knowing that so many other people in the country that are going through it, it makes it makes you feel a little bit less…weird. (female, 16)
I think because of the study there’s more structure to it, like I knew that it was only gonna be like 20 [sessions], and I knew when I’d be meet - there was just more, it was just more structured so I knew like how long I had… (female, 16)
I mean these little sessions were helpful in a way that I could…talk about most things, whereas I don’t really talk about any of this stuff with anyone else … they were helpful in that sort of way. (male, 17)
I don’t think it made any difference, because I was going to therapy anyway, so, I didn’t realise I was part of a study. Well it’s not that I didn’t realise it’s that I just, forgot about it. (female, 13)
A further 12 young people stated that their participation in the study did not come up in therapy, and this seemed to imply that because it did not come up in therapy, it did not have an impact on their outcomes.
This study aimed to investigate adolescents’ experiences of participating in an RCT. More specifically, the aim was to explore three areas in relation to the participant experience: motivation to participate, whether or not participation was found to be acceptable and what affected this, and whether and how participation had impacted on their experience of therapy and therapeutic change.
Regarding reasons for participating, Ferguson  reported that most adult patients do not feel they have a ‘moral duty’ to agree to take part in clinical trials, whereas McCann, Campbell and Entwistle  suggest that decisions to do so are often altruistic. McCann et al. highlighted the willingness to contribute towards furthering scientific knowledge as a major reason, but noted that this is best understood as a form of ‘conditional altruism’, as patients also hope that they will benefit themselves. This is consistent with the findings of our study, where a significant proportion (43 %) suggested that helping others and contributing to wider understanding was their main motivation for participating in the trial. Other reasons (such as the hope of getting quicker access to treatment, or simply because the research sounded interesting) might indicate a hope for more personal gain, but as with the findings of McCann et al.  regarding adults, these different motivations are not contradictory, and it may well be that a form of ‘conditional altruism’ was also characteristic of most young people.
To what degree their consent to participate can be considered fully informed, however, is questionable, as considerable levels of confusion existed among our participants about what a randomised clinical trial entails. The proportion of those who demonstrated understanding (45 %) was hardly different from those who appeared not to understand (43 %), with specific problems reported by a fair number of adolescents regarding their understanding of the process of randomisation or the difference between what was being offered in the three treatment arms. These findings mirror the results of studies on adult samples with similar rates of the ‘therapeutic misconception’ . In a qualitative interview study on middle-aged and older men with somatic prostatic diseases, most participants recalled major aspects of trial design, including the involvement of chance, but most also held other co-existing views about their treatment allocation like fate and individualised allocation . A similar struggle to recall the details of the study was reported for a sample of patients on anti-psychotic medication . In this study the confusion about trial processes and aims might have been due to difficulties recalling details of the informed consent that they were given weeks or months ago. Another possible explanation might be that some young people did not fully understand the study details in the first place, possibly as a result of their depression, which is often accompanied by difficulties with concentration .
Yet despite their limited understanding of the trial, having taken part in the IMPACT study the vast proportion of adolescents (93 %) found that it had been generally acceptable. In some cases this was because they had positively valued what taking part in the research had provided (e.g. helping them to reflect on progress or making them feel less isolated), but by far the greatest reason was because they had valued the relationships that they had formed with the research assistants who had undertaken the assessment meetings and were ‘the face’ of the study. The fact that these research assistants were friendly, flexible and engaging was key to the young people finding the study as a whole acceptable. Nevertheless, there were elements of the research with which they were not entirely happy. Whilst some elements were merely ‘awkward’ (such as the recording of therapy sessions), the greatest dissatisfaction was with the research questionnaires, which many young people felt to be overly time consuming, repetitive and in certain respects not meaningful. In some cases, this appears to have had a significant impact on the validity of the data produced, as some young people reported lacking the motivation to meaningfully respond to the questions.
These findings are consistent with studies examining the acceptability of trial design for adults in psychological therapy studies (e.g. [25–29]). For example, the young women with post-partum depression treatment in a study by Le et al.  spoke about finding questionnaires a helpful way to reflect on their own experiences. Furthermore, the young women formed relationships with the research team, which helped them to deal with feelings of isolation. Likewise, the young adults in a trial on social recovery CBT  generally reported quite high levels of acceptance regarding trial participation, although some aspects of the trial were criticized; for instance, some questions on the questionnaires were experienced as intrusive. Similar to the current study, the flexibility of the research assistants was an important aspect of acceptability.
The question of to what extent being part of the research impacted on the participants’ depression itself is a complex one, especially in a trial where the intervention is a ‘talking therapy’, which in some way has similarity to sitting down and speaking to a researcher. Our study suggests that a considerable minority of adolescents were confused about the difference between the research and the therapy or saw them as two aspects of the same thing. Interestingly, a considerable proportion of young people directly compared their experience of therapy with their meetings with the research assistants, sometimes preferring the latter because they were ‘friendlier’, ‘more flexible’ and the researchers were more like a peer than an adult. Clearly taking part in the research study did impact on their well-being—mostly in positive ways—such as reducing the sense of isolation or giving the young people an opportunity to reflect on the progress they had made. Although this is encouraging because it suggests that participating in an RCT of this sort was generally a positive experience for these young people, it does raise questions about the external validity of the findings and whether participating in the trial itself may have had a therapeutic impact.
Implications of the study for clinical trials evaluating the effectiveness of psychological therapies with adolescents
As with adults, a range of reasons explain why the young people have agreed to take part, but in most cases, a form of ‘conditional altruism’ exists; that is, they feel that taking part will help other people, but they also hope that it may have a range of benefits for themselves such as accessing treatment faster or receiving a more high-quality intervention.
Despite the under-representation of adolescents in clinical trials generally, when adolescents do take part in a clinical trial evaluating the effectiveness of psychological therapies, most young people generally find the experience acceptable.
Factors that contribute to trial participation being acceptable include the opportunity to reflect on the changes they have made by routinely reviewing their progress and the fact that research assistants were friendly, flexible and worked hard to engage with the young people. Clearly, recruiting highly motivated research assistants and giving them appropriate training and support to undertake this task is essential if a trial of this sort is to be successful.
Conversely, asking young people to fill in questionnaires that are repetitive or time consuming or that ask questions that do not seem relevant is likely to have a negative impact on their willingness to participate in clinical trials. Despite some concerns among psychotherapists, the recording of therapy sessions did not appear to be a major obstacle for the young people in the study.
Despite the general acceptability, greater effort needs to be made to ensure that consent to participate is truly informed. In particular, helping young people to understand what the different interventions involve and how the process of randomisation takes place may lead to a more fully informed consent process in clinical trials. Considering the role of the member of the research team taking informed consent seems relevant here. Helping those young people who seem to be struggling with understanding, on a case by case basis, may be an important start. It may also be that information sheets are not always fit for purpose, as there can be a requirement to include large amounts of information, even at the expense of making the information engaging and accessible. Including young people in the design of information sheets and developing innovative methods of explaining studies, rather than relying on more traditional patient information sheets, may be an important element of achieving this. For example, using interactive smart technology such as tablets to deliver the study information and take informed consent might help young people to engage with the information more fully. Some concerns also exist about the external validity of trial findings in the light of the findings of this study. In particular, where questionnaires are felt not to be meaningful, young people may not be filling them in carefully or truthfully. Likewise, the fact that the young people reported quite positive experiences of meeting with research assistants to review their progress also suggests that elements of the research protocol may have themselves been therapeutic, potentially distorting the findings of the study regarding clinical effectiveness. More caution may be needed in interpreting the effects of RCTs of psychological therapies, which are often considered the gold standard form of assessing clinical effectiveness, given the potential impact of the method itself on treatment outcomes.
Strengths and limitations of the study
The study reported here is one of the first to focus on the experience of young people taking part in a clinical trial evaluating the effectiveness of psychological therapies. The relatively large sample size, as well as findings based on in-depth interviews in which the young people had the opportunity to identify their own priorities and speak about what they considered to be most significant, add to the external validity of the study. This highlights the strengths and benefits of using qualitative research methods rather than pre-defined questionnaires or other methods of quantitative data collection.
Nevertheless, this study only included those who had already agreed to participate in the clinical trial, so some of the barriers to participation or reasons why young people might have chosen not to participate could not be identified. In addition, the adolescents who took part in the sub-study were only from one of the regions that were involved with the IMPACT study, so their experiences may not have reflected the experience of young people based in other regions, who also took part in this clinical trial. In addition, although the use of open-ended interviews had a number of benefits (especially in terms of allowing the young people to determine which aspects of participating in the study mattered to them), it did mean that the participants in the study were not all systematically asked about each element of trial participation (decision to join, understanding of the trial procedures, experience of participating, and impact on outcomes). For this reason, it was not always possible to give the exact proportions of young people who may have held various viewpoints. In particular, when topics were not mentioned by a particular participant, it is hard to say whether this reflects the fact that the topic was not important to them or whether they simply did not think to speak about it. As such, the current study is best seen as a preliminary exploratory study that has identified a range of experiences and views that adolescents could have when taking part in a clinical trial of this sort. Further research (e.g. using a standardized questionnaire) could build on this to systematically assess how common or uncommon such views are.
This study highlights the importance of giving young people who participate in clinical trials the opportunity to report on their own experience of taking part. In doing so, there are opportunities to better understand what motivates young people to take part; what makes such participation more or less acceptable; and to explore the impact of the trial participation itself on the clinical outcomes being evaluated. This study suggests a number of factors that need to be considered when designing trials of psychological therapies with young people and suggests that caution must be taken in the interpretation of trial outcomes, given the impact of the research framework itself.
BPI, Brief Psychosocial Intervention; CAMHS, Child and Adolescent Mental Health Service; CBT, cognitive behavioural therapy; ETI, Expectations of Therapy Interview; FA, framework analysis; IMPACT, Improving Mood through Psychoanalytic and Cognitive-Behavioural Therapy; RCT, randomised controlled trial; STPP, short-term psychoanalytic psychotherapy
This study was funded by the Monument Trust. We thank our colleagues who are working on, and the young people who took part in, the IMPACT study, as well as the other members of the IMPACT-ME team, including Sally Parkinson, Flavia Ansaldo, Emily Stapley and Virge Eatough.
NM conceived the study, participated in its design and coordination and worked on drafting the manuscript. DI carried out the qualitative analysis and helped to draft the manuscript. KW carried out the qualitative analysis and helped to draft the manuscript. MT participated in the study design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.
The authors declare that they have no competing interests.
Consent for publication
Written informed consent was obtained from the participants for publication of their individual details in this manuscript. The consent forms are held by the authors and are available for review by the Editor-in-Chief.
Ethics approval and consent to participate
The study protocol was approved by Cambridgeshire 2 Research Ethics Committee, Addenbrookes Hospital Cambridge, UK (REC Ref: 09/H0308/137), and informed written consent was obtained from all participants in the study, including parental consent for those participants under 16 years old. In order to protect confidentiality, identifiable details are excluded or disguised, and participants are described using only gender and age at the start of the study (e.g. ‘female, 15’).
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Fonagy P, Cottrell D, Phillips J, Bevington D, Glaser D, Allison E. What works for whom? A critical review of treatments for children and adolescents. 2nd ed. New York: Guilford Press; 2014.Google Scholar
- O’Cathain A, Thomas KJ, Drabble SJ, Rudolph A, Hewison J. What can qualitative research do for randomised controlled trials? A systematic mapping review. BMJ Open. 2013;3:e002889.View ArticlePubMedPubMed CentralGoogle Scholar
- Brown DL, Cowdery JE, Jones TS, Langford A, Gammage C, Jacobs TL. Adolescent knowledge and attitudes related to clinical trials. Clin Trials. 2015;12:212–4.View ArticlePubMedGoogle Scholar
- Notley C, Christopher R, Hodgekins J, Byrne R, French P, Fowler D. Participant views on involvement in a trial of social recovery cognitive-behavioural therapy. Br J Psychiatry. 2015;206:122–7.View ArticlePubMedGoogle Scholar
- Read K, Fernandez CV, Gao J, Strahlendorf C, Moghrabi A, Pentz RD, et al. Decision-making by adolescents and parents of children with cancer regarding health research participation. Pediatrics. 2009;124:959–65.View ArticlePubMedGoogle Scholar
- Shilling V, Young B. How do parents experience being asked to enter a child in a randomised controlled trial? BMC Med Ethics. 2009;10:1.View ArticlePubMedPubMed CentralGoogle Scholar
- Barakat LP, Patterson CA, Mondestin V, Chavez V, Austin T, Robinson MR, et al. Initial development of a questionnaire evaluating perceived benefits and barriers to pediatric clinical trials participation. Contemp Clin Trials. 2013;34:218–26.View ArticlePubMedGoogle Scholar
- Barakat LP, Schwartz LA, Reilly A, Deatrick JA, Balis F. A qualitative study of phase III cancer clinical trial enrollment decision-making: perspectives from adolescents, young adults, caregivers, and providers. J Adolesc Young Adult Oncol. 2014;3:3–11.View ArticlePubMedPubMed CentralGoogle Scholar
- Rothwell PM. External validity of randomised controlled trials: ‘To whom do the results of this trial apply?’. Lancet. 2005;365:82–93.View ArticlePubMedGoogle Scholar
- Goodyer IM, Tsancheva S, Byford S, Dubicka B, Hill J, Kelvin R, et al. Improving mood with psychoanalytic and cognitive therapies (IMPACT): a pragmatic effectiveness superiority trial to investigate whether specialised psychological treatment reduces the risk for relapse in adolescents with moderate to severe unipolar depres. Trials. 2011;12:175.View ArticlePubMedPubMed CentralGoogle Scholar
- Chambers WJ, Puig-Antich J, Hirsch M, Paez P, Ambrosini PJ, Tabrizi MA, et al. The assessment of affective-disorders in children and adolescents by semistructured interview - test-retest reliability of the Schedule for Affective-Disorders and Schizophrenia for school-age children, present episode version. Arch Gen Psychiatry. 1985;42:696–702.View ArticlePubMedGoogle Scholar
- Midgley N, Ansaldo F, Target M. The meaningful assessment of therapy outcomes: incorporating a qualitative study into a randomized controlled trial evaluating the treatment of adolescent depression. Psychotherapy. 2014;51:128–37.View ArticlePubMedGoogle Scholar
- Midgley N, Parkinson S, Holmes J, Stapley E, Eatough V, Target M. Beyond a diagnosis: the experience of depression among clinically-referred adolescents. J Adolesc. 2015;44:269–79. doi:10.1016/j.adolescence.2015.08.007.View ArticlePubMedGoogle Scholar
- Midgley N, Holmes J, Parkinson S, Stapley E, Eatough V, Target M. ‘Just like talking to someone about like shit in your life and stuff, and they help you’: hopes and expectations for therapy among depressed adolescents. Psychother Res. 2014. doi:10.1080/10503307.2014.973922.
- Stapley E, Target M, Midgley N. Experience of being the parent of an adolescent with a diagnosis of depression. J Child Fam Stud. 2016;25(2):618–30. doi:10.1007/s10826-015-0237-0.View ArticleGoogle Scholar
- Quinn PM. Qualitative research & evaluation methods. 4th ed. London: Sage; 2015.Google Scholar
- Ritchie J, Spencer L. Qualitative data analysis for applied policy research. In: Bryman A, Burgess RG, editors. Analyzing qualitative data. New York: Routledge; 1994. p. 173–94.View ArticleGoogle Scholar
- Srivastava A, Thomson SB. Framework analysis: A qualitative methodology for applied policy research. J Admin Gov. 2009;4:72–9.Google Scholar
- Bazeley P, Jackson K. Qualitative data analysis with NVivo. London: Sage; 2013.Google Scholar
- Parkinson S, Eatough V, Holmes J, Stapley E, Midgley N. Framework analysis: A worked example of a study exploring young people’s experiences of depression. Qual Res Psychol. 2016;13(2):109–29. doi:10.1080/14780887.2015.1119228.View ArticleGoogle Scholar
- Ferguson PR. Patients’ experiences and views of clinical trials. Med Law. 2001;20:143–52.PubMedGoogle Scholar
- McCann SK, Campbell MK, Entwistle VA. Reasons for participating in randomised controlled trials: conditional altruism and considerations for self. Trials. 2010;11:31. doi:10.1186/1745-6215-11-31.View ArticlePubMedPubMed CentralGoogle Scholar
- Appelbaum PS, Roth LH, Lidz CW, Benson P, Winslade W. False hopes and best data: consent to research and the therapeutic misconception. Hastings Cent Rep. 1987;17(2):20–4.View ArticlePubMedGoogle Scholar
- Featherstone K, Donovan JL. Why don’t they just tell me straight, why allocate it?’ The struggle to make sense of participating in a randomised controlled trial. Soc Sci Med. 2002;55:709–19.View ArticlePubMedGoogle Scholar
- Rogers A, Day J, Randall F, Bentall RP. Patients’ understanding and participation in a trial designed to improve the management of anti-psychotic medication: a qualitative study. Soc Psychiatry Psychiatr Epidemiol. 2003;38:720–7.View ArticlePubMedGoogle Scholar
- Biddle L, Cooper J, Owen-Smith A, Klineberg E, Bennewith O, Hawton K, et al. Qualitative interviewing with vulnerable populations: individuals’ experiences of participating in suicide and self-harm based research. J Affect Disord. 2013;145:356–62.View ArticlePubMedGoogle Scholar
- Kneipp SM, Lutz BJ, Levonian C, Cook C, Hamilton JB, Roberson D. Women’s experiences in a community-based participatory research randomized controlled trial. Qual Health Res. 2013;23:847–60.View ArticlePubMedGoogle Scholar
- Le H-N, Perry DF, Genovez M, Cardeli E. In their own voices: Latinas’ experiences with a randomized controlled trial. Qual Health Res. 2013;23:834–46.View ArticlePubMedGoogle Scholar
- Wootten AC, Abbott JM, Siddons HM, Rosenthal MA, Costello AJ. A qualitative assessment of the experience of participating in a cancer-related clinical trial. Support Care Cancer. 2011;19:49–55.View ArticlePubMedGoogle Scholar